Phase 2 non-randomised trial of secondary cytoreduction and hyperthermic intraperitoneal chemotherapy in recurrent platinum-sensitive ovarian cancer

BACKGROUND: The role of secondary cytoreduction with hyperthermic intraperitoneal chemotherapy (HIPEC) is not clearly defined in recurrent platinum-sensitive ovarian cancer (PSOC). There is a paucity of studies on secondary cytoreduction with HIPEC in PSOC from developing countries like India. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Raj, Hemanth, Keerthi, Marri Sri Santosh, Palaniappan, Ravisankar, Prakash, Ujwala, Dhanushkodi, Manikandan, Ganesan, Trivadi S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426017/
https://www.ncbi.nlm.nih.gov/pubmed/34567245
http://dx.doi.org/10.3332/ecancer.2021.1260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426017/
https://www.ncbi.nlm.nih.gov/pubmed/34567245
http://dx.doi.org/10.3332/ecancer.2021.1260

Ejemplares similares